Access Bio, Inc.

Access Bio is a global leader in in vitro diagnostics (IVD), dedicated to improving public health through the development, research, and manufacturing of high-quality diagnostic solutions. Specializing in rapid diagnostic tests, biosensors, and molecular diagnostics, Access Bio provides innovative and adaptable screening solutions for diseases such as malaria, COVID-19, and other infectious conditions. With a commitment to accessibility and accuracy, the company partners with international health organizations and public health agencies to ensure life-saving diagnostics reach those who need them most.

Offering comprehensive support services, Access Bio assists clients with packaging development, regulatory compliance, technical support, R&D consulting, and warehouse storage. Their cutting-edge diagnostic technology enables early detection and prevention, reinforcing their mission to safeguard global health. Through a proven track record in laboratory diagnostics and a focus on delivering high-quality solutions, Access Bio remains a trusted partner in the fight against infectious diseases worldwide.